4.7 Article

The structure of serine palmitoyltransferase; Gateway to sphingolipid biosynthesis

期刊

JOURNAL OF MOLECULAR BIOLOGY
卷 370, 期 5, 页码 870-886

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jmb.2007.04.086

关键词

serine palmitoyltransferase; sphingolipids; X-ray crystallography; bioinformatics; hereditary sensory and autonomic neuropathy type I

资金

  1. MRC [G0500367] Funding Source: UKRI
  2. Medical Research Council [G0500367] Funding Source: researchfish

向作者/读者索取更多资源

Sphingolipid biosynthesis commences with the condensation of L-serine and palmitoyl-CoA to produce 3-ketodihydrosphingosine (KDS). This reaction is catalysed by the PLP-dependent enzyme serine palmitoyltransferase (SPT; EC 2.3.1.50), which is a membrane-bound heterodirner (SPT1 SPT2) in eukaryotes such as humans and yeast and a cytoplasmic homodimer in the Gram-negative bacterium Sphingomonas pauchnobilis. Unusually, the outer membrane of S. paucimobilis contains glycosphingolipid (GSL) instead of lipopolysaccharide (LPS), and SPT catalyses the first crystal structure of the holo-form of S. paucimobilis SPT at 1.3 angstrom resolution. enzyme is a symmetrical homodimer with two active sites and monomeric tertiary structure consisting of three domains. The PLP cofactor is bound covalently to a lysine residue (Lys265) as an internal aldimine/ Schiff base and the active site is composed of residues from both subunits, located at the bottom of a deep cleft. Models of the human SPT1/SPT2 heterodimer were generated from the bacterial structure by bioinformatics analysis. Mutations in the human SPT1-encoding subunit have been shown to cause a neuropathological disease known as hereditary sensory and autonomic neuropathy type I (HSAN1). Our models provide an understanding of how these mutations may affect the activity of the enzyme. (c) 2007 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据